| Trait Information | |
| Identifier | MONDO_0021248 |
| Description | A neoplasm (disease) that involves the nervous system. [MONDO: patterns/location] | Trait category |
Other trait
|
| Synonyms |
10 synonyms
|
| Child trait(s) | 9 child traits |
| Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
|---|---|---|---|---|---|---|
| PGS000155 (cGRS_Glioma) |
PGP000075 | Shi Z et al. Cancer Med (2019) |
Glioma | glioma | 19 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000155/ScoringFiles/PGS000155.txt.gz |
| PGS000617 (PRSWEB_PHECODE190_20001-1030_PRS-CS_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Ocular cancer | ocular cancer | 834,009 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000617/ScoringFiles/PGS000617.txt.gz | |
| PGS000618 (PRSWEB_PHECODE191.1_GWAS-Catalog-r2019-05-03-X191.1_P_5e-08_UKB_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Brain and nervous system cancer | central nervous system cancer | 23 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000618/ScoringFiles/PGS000618.txt.gz | |
| PGS000619 (PRSWEB_PHECODE191.1_GWAS-Catalog-r2019-05-03-X191.1_PT_UKB_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Brain and nervous system cancer | central nervous system cancer | 19 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000619/ScoringFiles/PGS000619.txt.gz | |
| PGS000620 (PRSWEB_PHECODE191.11_C71_LASSOSUM_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Brain cancer | brain cancer | 522 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000620/ScoringFiles/PGS000620.txt.gz | |
| PGS000621 (PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_P_5e-08_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Brain cancer | brain cancer | 12 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000621/ScoringFiles/PGS000621.txt.gz | |
| PGS000622 (PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_P_5e-08_UKB_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Brain cancer | brain cancer | 12 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000622/ScoringFiles/PGS000622.txt.gz | |
| PGS000623 (PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_PT_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Brain cancer | brain cancer | 11 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000623/ScoringFiles/PGS000623.txt.gz | |
| PGS000624 (PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_PT_UKB_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Brain cancer | brain cancer | 5 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000624/ScoringFiles/PGS000624.txt.gz | |
| PGS000625 (PRSWEB_PHECODE191.11_UKBB-SAIGE-HRC-X191.11_PT_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Brain cancer | brain cancer | 11 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000625/ScoringFiles/PGS000625.txt.gz | |
| PGS000781 (GRS7_Glio) |
PGP000185 | Adel Fahmideh M et al. Sci Rep (2019) |
Glioma | glioma, brain neoplasm |
5 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000781/ScoringFiles/PGS000781.txt.gz |
| PGS001808 (portability-PLR_191.11) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Brain cancer | brain cancer | 117 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001808/ScoringFiles/PGS001808.txt.gz |
| PGS002261 (PRS22_NB) |
PGP000287 | Testori A et al. Cancer Epidemiol Biomarkers Prev (2022) |
Neuroblastoma | neuroblastoma | 22 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002261/ScoringFiles/PGS002261.txt.gz |
| PGS002302 (PRS28_glioma) |
PGP000328 | Choi J et al. Int J Cancer (2020) |
Glioma | glioma | 28 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002302/ScoringFiles/PGS002302.txt.gz |
| PGS003384 (best_GBM) |
PGP000413 | Namba S et al. Cancer Res (2022) |
Glioblastoma | glioblastoma | 910 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003384/ScoringFiles/PGS003384.txt.gz |
| PGS003737 (PRS26_BrC) |
PGP000470 | Xin J et al. EBioMedicine (2023) |
Brain cancer | brain neoplasm | 26 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003737/ScoringFiles/PGS003737.txt.gz | |
| PGS018460 (TPMI_145.2_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 11 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018460/ScoringFiles/PGS018460.txt.gz | |
| PGS018461 (TPMI_145.2_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 34,059 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018461/ScoringFiles/PGS018461.txt.gz | |
| PGS018462 (TPMI_145.2_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 570,182 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018462/ScoringFiles/PGS018462.txt.gz | |
| PGS018463 (TPMI_145.2_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 983,776 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018463/ScoringFiles/PGS018463.txt.gz | |
| PGS018464 (TPMI_145.2_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 1,003,968 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018464/ScoringFiles/PGS018464.txt.gz | |
| PGS018575 (TPMI_191_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Manlignant and unknown neoplasms of brain and nervous system | central nervous system cancer | 43 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018575/ScoringFiles/PGS018575.txt.gz | |
| PGS018576 (TPMI_191_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Manlignant and unknown neoplasms of brain and nervous system | central nervous system cancer | 90,905 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018576/ScoringFiles/PGS018576.txt.gz | |
| PGS018577 (TPMI_191_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Manlignant and unknown neoplasms of brain and nervous system | central nervous system cancer | 487,886 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018577/ScoringFiles/PGS018577.txt.gz | |
| PGS018578 (TPMI_191_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Manlignant and unknown neoplasms of brain and nervous system | central nervous system cancer | 983,826 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018578/ScoringFiles/PGS018578.txt.gz | |
| PGS018579 (TPMI_191_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Manlignant and unknown neoplasms of brain and nervous system | central nervous system cancer | 996,644 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018579/ScoringFiles/PGS018579.txt.gz | |
| PGS018630 (TPMI_225_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Benign neoplasm of brain and other parts of nervous system | benign neoplasm of peripheral nervous system | 105,501 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018630/ScoringFiles/PGS018630.txt.gz | |
| PGS018631 (TPMI_225_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Benign neoplasm of brain and other parts of nervous system | benign neoplasm of peripheral nervous system | 939,890 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018631/ScoringFiles/PGS018631.txt.gz | |
| PGS018632 (TPMI_225_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Benign neoplasm of brain and other parts of nervous system | benign neoplasm of peripheral nervous system | 18,584 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018632/ScoringFiles/PGS018632.txt.gz | |
| PGS018633 (TPMI_225_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Benign neoplasm of brain and other parts of nervous system | benign neoplasm of peripheral nervous system | 983,826 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018633/ScoringFiles/PGS018633.txt.gz | |
| PGS018634 (TPMI_225_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Benign neoplasm of brain and other parts of nervous system | benign neoplasm of peripheral nervous system | 994,892 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018634/ScoringFiles/PGS018634.txt.gz |
|
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|---|
| PPM000475 | PGS000155 (cGRS_Glioma) |
PSS000275| European Ancestry| 14,419 individuals |
PGP000075 | Shi Z et al. Cancer Med (2019) |
Reported Trait: Glioma | — | — | Mean realative risk: 1.22 [1.18, 1.26] Wilcoxon test (case vs. control) p-value: 1.39e-37 |
— | — |
| PPM000486 | PGS000155 (cGRS_Glioma) |
PSS000275| European Ancestry| 14,419 individuals |
PGP000075 | Shi Z et al. Cancer Med (2019) |
Reported Trait: Glioma | — | — | Odds Ratio (OR; high vs. average risk groups): 1.8 [1.55, 2.1] | — | — |
| PPM001302 | PGS000617 (PRSWEB_PHECODE190_20001-1030_PRS-CS_MGI_20200608) |
PSS000556| European Ancestry| 672 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of eye | OR: 1.339 [1.033, 1.736] β: 0.292 (0.132) |
AUROC: 0.586 [0.508, 0.658] | Nagelkerke's Pseudo-R²: 0.0152 Brier score: 0.0831 Odds Ratio (OR, top 1% vs. Rest): 4.74 [1.2, 18.7] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE190_20001-1030_PRS-CS_MGI_20200608 |
| PPM001303 | PGS000618 (PRSWEB_PHECODE191.1_GWAS-Catalog-r2019-05-03-X191.1_P_5e-08_UKB_20200608) |
PSS000578| European Ancestry| 3,110 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of brain and nervous system | OR: 1.569 [1.399, 1.759] β: 0.45 (0.0585) |
AUROC: 0.623 [0.592, 0.656] | Nagelkerke's Pseudo-R²: 0.0401 Brier score: 0.0812 Odds Ratio (OR, top 1% vs. Rest): 3.64 [1.76, 7.53] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE191.1_GWAS-Catalog-r2019-05-03-X191.1_P_5e-08_UKB_20200608 |
| PPM001304 | PGS000619 (PRSWEB_PHECODE191.1_GWAS-Catalog-r2019-05-03-X191.1_PT_UKB_20200608) |
PSS000578| European Ancestry| 3,110 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of brain and nervous system | OR: 1.564 [1.396, 1.753] β: 0.448 (0.0581) |
AUROC: 0.622 [0.59, 0.653] | Nagelkerke's Pseudo-R²: 0.0401 Brier score: 0.0812 Odds Ratio (OR, top 1% vs. Rest): 2.93 [1.34, 6.41] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE191.1_GWAS-Catalog-r2019-05-03-X191.1_PT_UKB_20200608 |
| PPM001305 | PGS000620 (PRSWEB_PHECODE191.11_C71_LASSOSUM_MGI_20200608) |
PSS000557| European Ancestry| 2,563 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of brain | OR: 1.195 [1.045, 1.367] β: 0.179 (0.0686) |
AUROC: 0.546 [0.504, 0.587] | Nagelkerke's Pseudo-R²: 0.00561 Brier score: 0.0824 Odds Ratio (OR, top 1% vs. Rest): 1.42 [0.453, 4.47] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE191.11_C71_LASSOSUM_MGI_20200608 |
| PPM001306 | PGS000621 (PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_P_5e-08_MGI_20200608) |
PSS000557| European Ancestry| 2,563 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of brain | OR: 1.159 [1.015, 1.324] β: 0.148 (0.068) |
AUROC: 0.54 [0.503, 0.579] | Nagelkerke's Pseudo-R²: 0.00394 Brier score: 0.0825 Odds Ratio (OR, top 1% vs. Rest): 1.02 [0.271, 3.86] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_P_5e-08_MGI_20200608 |
| PPM001307 | PGS000622 (PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_P_5e-08_UKB_20200608) |
PSS000577| European Ancestry| 3,020 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of brain | OR: 1.486 [1.315, 1.679] β: 0.396 (0.0624) |
AUROC: 0.605 [0.569, 0.639] | Nagelkerke's Pseudo-R²: 0.0289 Brier score: 0.0815 Odds Ratio (OR, top 1% vs. Rest): 3.38 [1.59, 7.2] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_P_5e-08_UKB_20200608 |
| PPM001308 | PGS000623 (PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_PT_MGI_20200608) |
PSS000557| European Ancestry| 2,563 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of brain | OR: 1.153 [1.01, 1.316] β: 0.142 (0.0676) |
AUROC: 0.538 [0.501, 0.577] | Nagelkerke's Pseudo-R²: 0.00369 Brier score: 0.0825 Odds Ratio (OR, top 1% vs. Rest): 0.602 [0.113, 3.22] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_PT_MGI_20200608 |
| PPM001309 | PGS000624 (PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_PT_UKB_20200608) |
PSS000577| European Ancestry| 3,020 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of brain | OR: 1.515 [1.344, 1.708] β: 0.415 (0.0611) |
AUROC: 0.606 [0.568, 0.642] | Nagelkerke's Pseudo-R²: 0.0326 Brier score: 0.0813 Odds Ratio (OR, top 1% vs. Rest): 4.15 [2.04, 8.41] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE191.11_GWAS-Catalog-r2019-05-03-X191.11_PT_UKB_20200608 |
| PPM001310 | PGS000625 (PRSWEB_PHECODE191.11_UKBB-SAIGE-HRC-X191.11_PT_MGI_20200608) |
PSS000557| European Ancestry| 2,563 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of brain | OR: 1.142 [1.004, 1.299] β: 0.133 (0.0657) |
AUROC: 0.53 [0.492, 0.57] | Nagelkerke's Pseudo-R²: 0.00328 Brier score: 0.0825 Odds Ratio (OR, top 1% vs. Rest): 2.28 [0.88, 5.88] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE191.11_UKBB-SAIGE-HRC-X191.11_PT_MGI_20200608 |
| PPM002036 | PGS000781 (GRS7_Glio) |
PSS001009| Multi-ancestry (including European)| 734 individuals |
PGP000185 | Adel Fahmideh M et al. Sci Rep (2019) |
Reported Trait: Pediatric brain tumors | OR: 1.25 [1.06, 1.49] | — | R²: 0.012 | Age, sex, country | — |
| PPM009371 | PGS001808 (portability-PLR_191.11) |
PSS007947| East Asian Ancestry| 1,801 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Cancer of brain | — | — | Partial Correlation (partial-r): 0.0004 [-0.0461, 0.0468] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009367 | PGS001808 (portability-PLR_191.11) |
PSS009278| European Ancestry| 19,895 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Cancer of brain | — | — | Partial Correlation (partial-r): 0.0144 | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009368 | PGS001808 (portability-PLR_191.11) |
PSS009052| European Ancestry| 4,114 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Cancer of brain | — | — | Partial Correlation (partial-r): 0.0179 [-0.0128, 0.0485] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009369 | PGS001808 (portability-PLR_191.11) |
PSS008606| European Ancestry| 6,626 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Cancer of brain | — | — | Partial Correlation (partial-r): 0.0237 | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009370 | PGS001808 (portability-PLR_191.11) |
PSS008160| South Asian Ancestry| 6,310 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Cancer of brain | — | — | Partial Correlation (partial-r): 0.0098 [-0.0149, 0.0345] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009372 | PGS001808 (portability-PLR_191.11) |
PSS007729| African Ancestry| 2,477 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Cancer of brain | — | — | Partial Correlation (partial-r): 0.0217 [-0.0179, 0.0612] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM009373 | PGS001808 (portability-PLR_191.11) |
PSS008832| African Ancestry| 3,913 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Cancer of brain | — | — | Partial Correlation (partial-r): 0.0343 [0.0029, 0.0657] | sex, age, birth date, deprivation index, 16 PCs | — |
| PPM012873 | PGS002261 (PRS22_NB) |
PSS009587| African Ancestry| 3,619 individuals |
PGP000287 | Testori A et al. Cancer Epidemiol Biomarkers Prev (2022) |
Reported Trait: Neuroblastoma risk | — | — | R²: 0.0203 | — | — |
| PPM013031 | PGS002302 (PRS28_glioma) |
PSS009663| European Ancestry| 312 individuals |
PGP000328 | Choi J et al. Int J Cancer (2020) |
Reported Trait: Glioma | — | AUROC: 0.61 [0.57, 0.64] | — | — | — |
| PPM013039 | PGS002302 (PRS28_glioma) |
PSS009663| European Ancestry| 312 individuals |
PGP000328 | Choi J et al. Int J Cancer (2020) |
Reported Trait: Glioma | — | — | Hazard ratio (HR top 5% vs average): 2.55 [1.72, 3.77] | Age, birth cohort, genotyping array, top 10 PCs for ancestry and sex (for nonsex specific cancer only) | — |
| PPM016259 | PGS003384 (best_GBM) |
PSS010078| European Ancestry| 269,806 individuals |
PGP000413 | Namba S et al. Cancer Res (2022) |
Reported Trait: glioblastoma | — | AUROC: 0.758 | R²: 0.0216 | age, sex, top 20 genetic principal components | — |
| PPM018493 | PGS003737 (PRS26_BrC) |
PSS010987| European Ancestry| 890 individuals |
PGP000470 | Xin J et al. EBioMedicine (2023) |
Reported Trait: Brain cancer | OR: 1.5 [1.38, 1.63] | — | — | — | — |
| PPM036642 | PGS018460 (TPMI_145.2_Lassosum2) |
PSS012358| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68616 | R²: 0.01171 | sex, age, array, PCs 1-10 | — |
| PPM036643 | PGS018461 (TPMI_145.2_LDpred2) |
PSS012357| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68599 | R²: 0.01168 | sex, age, array, PCs 1-10 | — |
| PPM036644 | PGS018462 (TPMI_145.2_MegaPRS) |
PSS012359| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68604 | R²: 0.0117 | sex, age, array, PCs 1-10 | — |
| PPM036645 | PGS018463 (TPMI_145.2_PRS-CS) |
PSS012360| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68622 | R²: 0.0117 | sex, age, array, PCs 1-10 | — |
| PPM036646 | PGS018464 (TPMI_145.2_SBayesR) |
PSS012361| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68563 | R²: 0.01173 | sex, age, array, PCs 1-10 | — |
| PPM036757 | PGS018575 (TPMI_191_Lassosum2) |
PSS012478| East Asian Ancestry| 19,669 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Manlignant and unknown neoplasms of brain and nervous system | — | AUROC: 0.69472 | R²: 0.01255 | sex, age, array, PCs 1-10 | — |
| PPM036758 | PGS018576 (TPMI_191_LDpred2) |
PSS012477| East Asian Ancestry| 19,669 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Manlignant and unknown neoplasms of brain and nervous system | — | AUROC: 0.69446 | R²: 0.01254 | sex, age, array, PCs 1-10 | — |
| PPM036759 | PGS018577 (TPMI_191_MegaPRS) |
PSS012479| East Asian Ancestry| 19,669 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Manlignant and unknown neoplasms of brain and nervous system | — | AUROC: 0.69455 | R²: 0.0126 | sex, age, array, PCs 1-10 | — |
| PPM036760 | PGS018578 (TPMI_191_PRS-CS) |
PSS012480| East Asian Ancestry| 19,669 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Manlignant and unknown neoplasms of brain and nervous system | — | AUROC: 0.69562 | R²: 0.01269 | sex, age, array, PCs 1-10 | — |
| PPM036761 | PGS018579 (TPMI_191_SBayesR) |
PSS012481| East Asian Ancestry| 19,669 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Manlignant and unknown neoplasms of brain and nervous system | — | AUROC: 0.69618 | R²: 0.01269 | sex, age, array, PCs 1-10 | — |
| PPM036812 | PGS018630 (TPMI_225_Lassosum2) |
PSS012533| East Asian Ancestry| 19,663 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Benign neoplasm of brain and other parts of nervous system | — | AUROC: 0.66017 | R²: 0.00803 | sex, age, array, PCs 1-10 | — |
| PPM036813 | PGS018631 (TPMI_225_LDpred2) |
PSS012532| East Asian Ancestry| 19,663 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Benign neoplasm of brain and other parts of nervous system | — | AUROC: 0.66156 | R²: 0.00841 | sex, age, array, PCs 1-10 | — |
| PPM036814 | PGS018632 (TPMI_225_MegaPRS) |
PSS012534| East Asian Ancestry| 19,663 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Benign neoplasm of brain and other parts of nervous system | — | AUROC: 0.66091 | R²: 0.00806 | sex, age, array, PCs 1-10 | — |
| PPM036815 | PGS018633 (TPMI_225_PRS-CS) |
PSS012535| East Asian Ancestry| 19,663 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Benign neoplasm of brain and other parts of nervous system | — | AUROC: 0.65907 | R²: 0.00795 | sex, age, array, PCs 1-10 | — |
| PPM036816 | PGS018634 (TPMI_225_SBayesR) |
PSS012536| East Asian Ancestry| 19,663 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Benign neoplasm of brain and other parts of nervous system | — | AUROC: 0.65916 | R²: 0.00802 | sex, age, array, PCs 1-10 | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS000556 | PheCode:190; ICD9CM:190.0, 190.1, 190.2, 190.3, 190.4, 190.5, 190.6, 190.7, 190.8, 190.9, 234.0, V10.84; ICD10CM:C69, C69.0, C69.00, C69.01, C69.02, C69.1, C69.10, C69.11, C69.12, C69.2, C69.20, C69.21, C69.22, C69.3, C69.30, C69.31, C69.32, C69.4, C69.40, C69.41, C69.42, C69.5, C69.50, C69.51, C69.52, C69.6, C69.60, C69.61, C69.62, C69.8, C69.80, C69.81, C69.82, C69.9, C69.90, C69.91, C69.92, D09.2, D09.20, D09.21, D09.22 | — | [
|
— | European | — | MGI | — |
| PSS000557 | PheCode:191.11; ICD9CM:191.0, 191.1, 191.2, 191.3, 191.4, 191.5, 191.6, 191.7, 191.8, 191.9, V10.85; ICD10CM:C71, C71.0, C71.1, C71.2, C71.3, C71.4, C71.5, C71.6, C71.7, C71.8, C71.9 | — | [
|
— | European | — | MGI | — |
| PSS010987 | — | — | 890 individuals | Mean = 50.88 years | European | — | TCGA | — |
| PSS000577 | PheCode:191.11; ICD9:191, 191.0, 191.1, 191.2, 191.3, 191.4, 191.5, 191.6, 191.7, 191.8, 191.9; ICD10:C71.0, C71.1, C71.2, C71.3, C71.4, C71.5, C71.6, C71.7, C71.8, C71.9 | — | [
|
— | European | — | UKB | — |
| PSS000578 | PheCode:191.1; ICD9:192, 192.0, 192.1, 192.2, 192.3, 192.8, 192.9; ICD10:C70.0, C70.1, C70.9, C71.0, C71.1, C71.2, C71.3, C71.4, C71.5, C71.6, C71.7, C71.8, C71.9, C72.0, C72.1, C72.2, C72.3, C72.4, C72.5, C72.8, C72.9 | — | [
|
— | European | — | UKB | — |
| PSS009052 | — | — | 4,114 individuals | — | European | Poland (NE Europe) | UKB | — |
| PSS008160 | — | — | 6,310 individuals | — | South Asian | India (South Asia) | UKB | — |
| PSS009587 | — | — | [
|
— | African American or Afro-Caribbean (African American) |
— | COG | — |
| PSS008832 | — | — | 3,913 individuals | — | African unspecified | Nigeria (West Africa) | UKB | — |
| PSS012477 | 191, 192, 237.5, 237.6, 239.6, V10.85, V10.86,C70, C71, C72, D42, D43.0, D43.1, D43.2, D43.4, D49.6, Z85.841, Z85.848 | — | [ ,
46.09 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012478 | 191, 192, 237.5, 237.6, 239.6, V10.85, V10.86,C70, C71, C72, D42, D43.0, D43.1, D43.2, D43.4, D49.6, Z85.841, Z85.848 | — | [ ,
46.09 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012479 | 191, 192, 237.5, 237.6, 239.6, V10.85, V10.86,C70, C71, C72, D42, D43.0, D43.1, D43.2, D43.4, D49.6, Z85.841, Z85.848 | — | [ ,
46.09 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012480 | 191, 192, 237.5, 237.6, 239.6, V10.85, V10.86,C70, C71, C72, D42, D43.0, D43.1, D43.2, D43.4, D49.6, Z85.841, Z85.848 | — | [ ,
46.09 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012481 | 191, 192, 237.5, 237.6, 239.6, V10.85, V10.86,C70, C71, C72, D42, D43.0, D43.1, D43.2, D43.4, D49.6, Z85.841, Z85.848 | — | [ ,
46.09 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS007947 | — | — | 1,801 individuals | — | East Asian | China (East Asia) | UKB | — |
| PSS012357 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012358 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012359 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012360 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012361 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS010078 | C71, histology was either Giant cell glioblastoma or Glioblastoma (NOS) | — | [
|
— | European (British) |
— | UKB | Controls were samples without any cancer diagnosis or self-reported cancer |
| PSS000275 | Primary tumor samples from TCGA | — | [
|
Mean = 52.0 years Sd = 16.0 years |
European | — | TCGA | — |
| PSS000275 | — | — | [
|
— | European | — | eMERGE | — |
| PSS008606 | — | — | 6,626 individuals | — | European | Italy (South Europe) | UKB | — |
| PSS009663 | glioma (ICD-9 = 191 or ICD-10 = C71; ICD-O: 9380-9480) | — | 312 individuals | — | European | — | UKB | — |
| PSS012533 | 225, V12.41,D32.0, D32.1, D32.9, D33.0, D33.1, D33.2, D33.3, D33.4, D33.7, D33.9, Z86.011 | — | [ ,
46.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS007729 | — | — | 2,477 individuals | — | African American or Afro-Caribbean | Carribean | UKB | — |
| PSS012535 | 225, V12.41,D32.0, D32.1, D32.9, D33.0, D33.1, D33.2, D33.3, D33.4, D33.7, D33.9, Z86.011 | — | [ ,
46.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012532 | 225, V12.41,D32.0, D32.1, D32.9, D33.0, D33.1, D33.2, D33.3, D33.4, D33.7, D33.9, Z86.011 | — | [ ,
46.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS001009 | Cases include participants with the following tumors: Astrocytomas (ICCC-3 group IIIb), Other gliomas (ICCC-3 group IIId), Ependymomas (ICCC-3 group IIIa), Intracranial embryonal tumors (ICCC-3 group IIIc), other specified intracranial neoplasms (ICCC-3 group IIIe), unspecified intracranial neoplasms (ICCC-3 group IIIf) | — | [ ,
54.09 % Male samples |
— | European, NR | European = 454, NR =280 | CEFALO | — |
| PSS012534 | 225, V12.41,D32.0, D32.1, D32.9, D33.0, D33.1, D33.2, D33.3, D33.4, D33.7, D33.9, Z86.011 | — | [ ,
46.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS009278 | — | — | 19,895 individuals | — | European | UK (+ Ireland) | UKB | — |
| PSS012536 | 225, V12.41,D32.0, D32.1, D32.9, D33.0, D33.1, D33.2, D33.3, D33.4, D33.7, D33.9, Z86.011 | — | [ ,
46.15 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |